Over-the-counter drug · OTC MONOGRAPH FINAL
Motion Sickness Relief (meclizine hcl) NDC 51013-322
Meclizine hydrochloride 25 mg/1 · Tablet, Chewable · Oral · PuraCap Pharmaceutical LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 51013-322-54 | 51013032254 | 15 POUCH in 1 CARTON (51013-322-54) / 2 TABLET, CHEWABLE in 1 POUCHMarketed from Nov 28, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Motion Sickness Relief
- Generic name (nonproprietary)
- meclizine hcl
- Active ingredients
- Meclizine hydrochloride — 25 mg/1
- Dosage form
- Tablet, Chewable
- Route
- Oral
- Labeler
- PuraCap Pharmaceutical LLC
- Product type
- Over-the-counter drug
- Marketing category
- OTC monograph (final)Application part336
- Marketing start
- Listing expires
- Other FDA classes
- Emesis Suppression (Physiologic effect)
- Identifiers
- Product ID 51013-322_116d1b6a-03af-4b3c-a81a-e1a598bf4f6bSPL ID 116d1b6a-03af-4b3c-a81a-e1a598bf4f6bSPL set ID 8d772ff0-1476-48ca-a7e4-9473ce3db83aRxCUI 995632UNII HDP7W44CIO
- Pharmacologic class
- Antiemetic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N451013032254followed by a unit qualifier and the quantityPackage 51013-0322-54. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness
Excerpt only. Read the full label for complete information.
Other NDCs under part336
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Meclizine HCL 25 mgmeclizine hcl | Meclizine hydrochloride 25 mg/1 | TabletOral | Preferred Pharmaceuticals Inc. | 68788-7982 |
| Meclizine HCLmeclizine hcl 25mg chewable tablets | Meclizine hydrochloride 25 mg/1 | Tablet, ChewableOral | Richmond Pharmaceuticals, Inc. | 54738-025 |
| Motion Sickness Reliefmeclizine hcl | Meclizine hydrochloride 25 mg/1 | Tablet, ChewableOral | CVS PHARMACY, INC. | 69842-395 |
| Meclizine HCLmeclizine hcl 25mg chewable tablets | Meclizine hydrochloride 25 mg/1 | Tablet, ChewableOral | Advance Pharmaceutical Inc. | 17714-115 |
| Meclizine HCL 12.5 mg | Meclizine hydrochloride 12.5 mg/1 | TabletOral | Advance Pharmaceutical Inc. | 17714-117 |
| Meclizinemeclizine hcl 25mg | Meclizine hydrochloride 25 mg/1 | Tablet, ChewableOral | Bryant Ranch Prepack | 71335-1215 |
| Motion-Time Chewablemeclizine hcl | Meclizine hydrochloride 25 mg/251 | Tablet, ChewableOral | Time-Cap Labs, Inc | 49483-333 |